So while the cap raise has easily been filled the Bot team will be busy preparing for filing the SB NDA for the FDA. The process is as follows:
https://www.fda.gov/patients/drug-development-process/step-4-fda-drug-review
Once this accepted hopefully on the 19th of this month there should be another SP uptick. Successful filing will be a significant landmark for BOT.
Just look to the Neuren pharmaceuticals share price today. Acadia just received FDA filing acceptance for its new orphan drug. This is the sort of example to watch.
Pending announcements Q3 and Q4, page-61
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $696.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.5¢ | 37.5¢ | $4.475M | 11.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 37310 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 54981 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |